pioglitazone has been researched along with Necrotizing Enterocolitis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corsini, I | 1 |
| Polvani, S | 1 |
| Tarocchi, M | 1 |
| Tempesti, S | 1 |
| Marroncini, G | 1 |
| Generoso, M | 1 |
| Bresci, C | 1 |
| Gozzini, E | 1 |
| Bianconi, T | 1 |
| Galli, A | 1 |
| Dani, C | 1 |
1 other study available for pioglitazone and Necrotizing Enterocolitis
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-γ agonist pioglitazone reduces the development of necrotizing enterocolitis in a neonatal preterm rat model.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Enterocoliti | 2017 |